BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6837591)

  • 1. The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Sindler BH; Griffing GT; Melby JC
    Am J Med; 1983 Apr; 74(4):657-62. PubMed ID: 6837591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome.
    Avgerinos PC; Nieman LK; Oldfield EH; Cutler GB
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):483-91. PubMed ID: 8959090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of steroid laboratory tests and adrenal gland imaging with radiocholesterol in the aetiological diagnosis of Cushing's syndrome.
    Barbarino A; de Marinis L; Liberale I; Menini E
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):107-21. PubMed ID: 428112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison.
    Avgerinos PC; Yanovski JA; Oldfield EH; Nieman LK; Cutler GB
    Ann Intern Med; 1994 Sep; 121(5):318-27. PubMed ID: 8042820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Contreras LN; Gómez RM; Galparsoro G; Cazado E; Kral M; Leber B; Arias D
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):158-62. PubMed ID: 2990131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    Lancet; 1986 Sep; 2(8506):540-4. PubMed ID: 2875282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease.
    Lamberts SW; Klijn JG; de Jong FH; Birkenhäger JC
    JAMA; 1979 Oct; 242(15):1640-3. PubMed ID: 39183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cortisol levels in Cushing's syndrome after low- and high-dose dexamethasone suppression.
    Ashcraft MW; Van Herle AJ; Vener SL; Geffner DL
    Ann Intern Med; 1982 Jul; 97(1):21-6. PubMed ID: 6212010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's syndrome: a review of diagnostic tests.
    Crapo L
    Metabolism; 1979 Sep; 28(9):955-77. PubMed ID: 225638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.